POSTN and lung cancer: A statistically significant decrease in invasiveness was found in lung cancer cells, silencing POSTN (A549.shRNA) compared to the control cells (A549.CTRL) at the 24th, 48th, and 72nd hours of the experiment (*** p < 0.001, respectively; Bonferroni multiple comparisons) (Figure 10).